| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 17 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 |
| 2 | TACROLIMUS OINTMENT 0.1% | 17 |
| 3 | PREDNISONE | 12 |
| 4 | AZATHIOPRINE | 9 |
| 5 | EVEROLIMUS | 5 |
| 6 | EVEROLIMUS TABLETS | 5 |
| 7 | BLEOMYCIN SULFATE | 3 |
| 8 | PREDNISOLONE | 3 |
| 9 | PREDNISOLONE ORAL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEMIGATINIB | 1 | 0.0012 |
| 1 | EVEROLIMUS TABLETS | 5 | 0.0003 |
| 2 | BLEOMYCIN SULFATE | 3 | 0.0003 |
| 3 | MITOMYCIN | 1 | 0.0003 |
| 4 | DACARBAZINE | 2 | 0.0003 |
| 5 | TACROLIMUS OINTMENT 0.1% | 17 | 0.0001 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 17 | 0.0001 |
| 7 | TACROLIMUS | 17 | 0.0001 |
| 8 | AZATHIOPRINE | 9 | 0.0001 |
| 9 | EVEROLIMUS | 5 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 15 |
| 1 | Purine Antimetabolite [EPC] | 9 |
| 2 | Kinase Inhibitor [EPC] | 7 |
| 3 | mTOR Inhibitor Immunosuppressant [EPC] | 5 |
| 4 | Alkylating Drug [EPC] | 4 |
| 5 | Janus Kinase Inhibitor [EPC] | 2 |
| 6 | Antimetabolite [EPC] | 1 |
| 7 | Aromatase Inhibitor [EPC] | 1 |
| 8 | Microtubule Inhibitor [EPC] | 1 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Purine Antimetabolite [EPC] | 9 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | beta3-Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 4 | Kinase Inhibitor [EPC] | 7 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Corticosteroid [EPC] | 15 | 0.0000 |
| 7 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 1 | 0.0000 |